Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GM MEDICAL LASERS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   9.6% 10.4% 12.2% 6.7% 8.9% 6.1% 16.0% 16.0%   Credit score (0-100)   27 25 19 34 27 37 12 12   Credit rating   BB BB BB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 -0.0 -0.0 -0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   194 -194 -402 953 995 997 0.0 0.0   EBITDA   79.5 -360 -547 522 446 513 0.0 0.0   EBIT   79.5 -360 -547 522 446 448 0.0 0.0   Pre-tax profit (PTP)   -178.8 -627.7 -739.5 465.8 392.7 362.1 0.0 0.0   Net earnings   -139.5 -489.6 -739.8 423.8 306.6 293.7 0.0 0.0   Pre-tax profit without non-rec. items   -179 -628 -739 466 393 362 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 262 0.0 0.0   Shareholders equity total   -60.8 -550 -1,290 -866 -560 -266 -391 -391   Interest-bearing liabilities   4,062 3,494 4,593 3,686 3,089 3,546 391 391   Balance sheet total (assets)   6,315 4,651 4,733 4,071 3,857 4,154 0.0 0.0   Net Debt   4,050 3,453 4,574 3,667 3,059 3,540 391 391     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   194 -194 -402 953 995 997 0.0 0.0   Gross profit growth   -78.2% 0.0% -106.6% 0.0% 4.5% 0.2% -100.0% 0.0%   Employees   0 0 0 0 0 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,315 4,651 4,733 4,071 3,857 4,154 0 0   Balance sheet change%   103.4% -26.3% 1.8% -14.0% -5.2% 7.7% -100.0% 0.0%   Added value   79.5 -359.8 -546.9 521.7 445.9 512.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 198 -262 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   41.0% 185.1% 136.2% 54.8% 44.8% 44.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.0% -6.2% -9.6% 9.9% 9.7% 10.3% 0.0% 0.0%   ROI %   2.9% -9.5% -13.3% 13.2% 13.4% 13.8% 0.0% 0.0%   ROE %   -4.4% -8.9% -15.8% 9.6% 7.7% 7.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -1.0% -10.6% -21.4% -17.5% -12.7% -6.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   5,095.5% -959.6% -836.3% 702.8% 686.0% 690.6% 0.0% 0.0%   Gearing %   -6,678.2% -634.7% -356.0% -425.4% -551.9% -1,333.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.5% 7.1% 5.0% 1.9% 1.8% 2.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.4 0.2 0.2 0.0 0.2 0.0 0.0   Current Ratio   1.0 0.9 0.8 0.8 0.9 0.9 0.0 0.0   Cash and cash equivalent   11.7 40.6 19.1 19.1 30.2 6.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -60.8 -550.4 -1,290.2 -866.4 -559.8 -527.4 -195.5 -195.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 256 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 256 0 0   EBIT / employee   0 0 0 0 0 224 0 0   Net earnings / employee   0 0 0 0 0 147 0 0